ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 3 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Superinvestors holding IBRX, Q2 2026

See all superinvestors

No superinvestor reported holding IBRX in Q2 2026.